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Abstract
Advanced echocardiography techniques such as speckle tracking imaging are sensitive diagnostic tools frequently
used in various clinical and scientific scenarios. Importantly, imperfect reproducibility and dependence of post-
processing algorithms on echocardiographic image quality are potential methodological limitations. Therefore,
meticulous assessment of data quality and detailed reporting of study methodology, sample specifics, technical
peculiarities and measurement conditions are crucial. Unfortunately, despite the recognized importance of this,
there is still no broadly accepted standard for assessing the quality of echocardiographic images in clinical research
reports. This article quintessentially highlights important shortcomings of data quality assessment and
methodological study design, commonly occurring in clinical research reports using advanced echocardiography
techniques. Finally, suggestions are made as to how researchers, scientific communities and biomedical journals can
contribute to the ever-lasting process of improving the quality of clinical research in cardiovascular imaging.
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Background
I read with great interest the recent article entitled “Left
ventricular short-axis systolic function changes in pa-
tients with hypertrophic cardiomyopathy detected by
two-dimensional speckle tracking imaging” by Huang
et al., published in BMC Cardiovascular Disorders [1].
While the medical topic and chosen methodology (i.e.
layer-specific myocardial deformation assessment) are
important and the article undoubtedly provides interest-
ing insights, it also elicits the need for an overdue focus
on data quality assessment, (non-)standardized research
reporting, and benchmarking of biomedical imaging
studies in clinical science.
Cardiovascular ultrasound and its quantitative add-on
speckle tracking echocardiography are powerful diagnostic
tools both in biomedical research and clinical practice.
However, echocardiographic validity is limited by real and
perceived suboptimal measurement reproducibility [2, 3].
Therefore, caution must be paid when using this sensitive
tool. Specifically, rigorous reporting of the research set-
ting, methodological design, study samples, measurement
conditions and data quality are key prerequisites to inter-
pret research results in the right light. Unfortunately, hith-
erto there is still no broadly accepted standard for
assessing the quality of echocardiographic measurements,
let alone mandatory reporting standards in clinical re-
search studies using biomedical imaging techniques.
Main text
The study by Huang and colleagues is a useful example
of learning points and room for improvement that con-
cern many timely reports using quantitative biomedical
imaging such as speckle-tracking echocardiography.
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Regarding echocardiography-specific study features, the
methodological design lacks three important quality as-
surance measures: echocardiographic image quality
reporting, examiner blinding to subjects’ study cohort af-
filiation, and inter-observer variability testing.
First, we and others have shown the varying influence of
echocardiographic image quality for myocardial deform-
ation analyses using speckle tracking echocardiography [4]
and other quantitative assessments [5]. Importantly, sub-
standard images may yield “implausibly normal” deform-
ation parameters and are therefore prone to result in
misinterpretation of potentially impaired myocardial
mechanics. In addition to image quality, other key features
such as foreshortening of the views [6, 7], sampling frame
rate [8], heart rate [9] and LV morphology [10] may affect
the measurements performed by speckle tracking echocar-
diography. A critical review of current approaches for echo-
cardiographic quality benchmarking in clinical research
recently pointed out, that despite its recognized import-
ance, there is still no broadly accepted standard for asses-
sing the quality of echocardiographic measurements in
clinical research reports [11]. Nevertheless, researchers
should make an effort to overcome this gap, e.g. by docu-
menting at least the number of non-visualized or excluded
viewing planes and segments. Moreover, societies and
working groups should establish and validate a uniformly-
accepted quality scoring system and reporting standards for
biomedical imaging, such as the famous CONSORT state-
ment for the reporting of clinical trials [12]. A step in the
right direction is the EACVI/ASE/Industry Task Force’s sig-
nificant efforts to standardize LA, RA and RV deformation
imaging [13]. However, their focus was purely clinical, thus
of little help to matters of strain imaging data acquisition
and reporting in research. A similar endeavor for the scien-
tific use of quantitative echocardiography ought to follow.
Once established, biomedical journals should make these
standards mandatory for scientific publishing, to increase
adherence to these important recommendations.
Second, other than this society-based shortcoming, the
importance of blinding in clinical studies has long been
established [14]. Therefore, the reason for the lack of
examiner blinding to subjects’ study cohort affiliation in
Huang’s work remains unclear. The risk of bias is high if
adequate blinding is not used, as proven by strong em-
pirical evidence published two decades ago [15]. Hence,
researchers, ethics committees and biomedical editors
should avoid the design (permission, or publication, re-
spectively) of unblinded clinical studies as appropriate,
and continue on an ever-improving – yet often rocky -
road to excellence and scientific rigor in clinical research
design.
Third, given the known variances in echocardiographic
reproducibility, the absence of inter-observer variation
testing in Huan’s study is a surprising limitation. Even
well-conducted large trials have yielded low interobserver
reproducibility (coefficient of variation increasing 70%)
and a large proportion of non-assessable echocardiographs
(e.g. up to 50% of tissue-Doppler imaging), which makes
the study findings hard to interpret [2]. Therefore, the as-
sessment of reproducibility for sensitive diagnostic tools in
clinical research should become a conditio sine qua non.
For the sake of completeness, two non-
echocardiography-specific limitations in the study of Huang
et al. deserve mention. The amount of statistical compari-
sons and p-value calculations without Bonferroni correction
or prospective prioritization constitute a biostatistical weak-
ness. In light of the controversial nature of Bonferroni
correction and its newer alternatives [16], reducing the
risk of a false negative outcome (the type II error),
should be achieved by increasing sample size when
multiplicity corrections are performed. Finally, elegantly
conducted and widely cited works had delivered con-
flicting results, as compared to the present study, and
therefore deserve to be critically discussed [17, 18].
Conclusion
As a scientific community, we owe our readership – and
our patients – thorough methodological study designs as
well as rigorous analyses of both the promising findings
as well the potential limitations and, ultimately, the
learning opportunities that each study brings to the
table. The lack of benchmarking and standardized qual-
ity assurance in biomedical imaging is a ubiquitous chal-
lenge that ought to be addressed by study designers and
scientific societies in the future.
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Author’s response
Jun Huang
Thank you very much for your letter. I wish to publish a
response to the correspondence “Time to shape up - as-
sessment and reporting standards for data quality in
clinical research using echocardiographic imaging tech-
niques require improvement”.
Responses to the article:
Thanks for the critical comments to our group about the
article “Left ventricular short-axis systolic function changes in
patients with hypertrophic cardiomyopathy detected by two-
dimensional speckle tracking imaging” [1]. Dr. Hensel mainly
presented three main problems, which include echocardio-
graphic image quality reporting, examiner blinding to sub-
jects’ study cohort affiliation, and inter-observer variability
testing.
Firstly, echocardiographic image quality reporting, in
our study [1], all echocardiographic images or videos
were acquired by an experienced chief physician who
was a specialist in echocardiography. All of these images
or videos were clear and could be analyzed by EchoPAC
software. If hypertrophic cardiomyopathic patients or
normal control subjects presented poor echocardio-
graphic images or videos, we excluded these patients
from the analysis.
Secondly, examiner blinding to subjects’ study cohort
affiliation is really important to our research. However,
in this this study [1], we enrolled hypertrophic cardio-
myopathic patients and normal subjects for detecting left
ventricular (dys)-function. The experimental design was
“blinded”, although an experienced echocardiography
consulant, could diagnosis the hypertrophic cardiomyo-
pathic patients form the images and videos quickly.
Thirdly, in this study [1], we ignored the inter-
observer variability testing. All the results were mea-
sured by the author of this correspondence. Inter-
observer and intra- observer variability testing are very
important for the reliability in the clinical research. In
our future research, we have included the inter- observer
and intra- observer variability testing in our manuscript.
Thanks to Dr. Hensel, I and my group members agree
with the recommendation about the standard for the
quality of echocardiographic measurements, “blinding”
analysis and variability testing, and these elements are
very crucial for ongoing and future clinical research.
Finally, I have a suggestion, Dr. Hensel should make a
“model” example in a future piece, because most publi-
cations have the same issues, and he help propose the
standard for future research. Thank for the critical ad-
vice once again.
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